Van Niekerk, Andre; Delport, Suzanne D.(Allergy Society of South Africa, 2024-06-01)
The past two decades will be remembered for the rapid advances in our understanding of the significant role that the human
microbiome plays in health, illness and longevity, but it remains a vast concept, one that is ...
Mercier, Anne Elisabeth; Joubert, Anna Margaretha; Viallet, Jean; Desroches-Castan, Agnes; De Koning, Leanne; Mabeta, Peaceful Lucy; Helena, Jolene Michelle; Pepper, Michael Sean; Lafanechere, Laurence(MDPI, 2024-10)
The microtubule-disrupting agent 2-methoxyestradiol (2-ME) displays anti-tumor and
anti-angiogenic properties, but its clinical development is halted due to poor pharmacokinetics. We
therefore designed two 2-ME analogs ...
BACKGROUND :
Ex vivo haematopoietic stem/progenitor cell (HSPCs) expansion constitutes an important area of research, and has the potential to improve access to umbilical cord blood (UCB) as a source of stem cells for ...
Castelyn, Camille De Villebois; Van Staden, Werdie; Pepper, Michael Sean(Frontiers Media, 2024-02)
BACKGROUND AND OBJECTIVE: The possibility of using human cloning to
reproduce has been met with unease, shock, and prohibition in many countries,
as well as the International Committee for Monitoring Assisted ...
Hart, Daniel William; Roberts, Elise; O'Riain, M. Justin; Millar, Robert P.; Bennett, Nigel C.(Wiley, 2024-10)
The naked mole-rat (Heterocephalus glaber) is a unique model mammal in which to study socially induced inhibition of the hypothalamic–pituitary–gonadal (HPG) axis. Naked mole-rat groups exhibit a high degree of reproductive ...
The clinical significance of the tumor-immune interaction in breast cancer is now established, and tumor-infiltrating
lymphocytes (TILs) have emerged as predictive and prognostic biomarkers for patients with triple-negative ...
Measures of physical growth, such as weight and height have long been the predominant outcomes for monitoring child health and evaluating interventional outcomes in public health studies, including those that may impact ...
Chiveto, Dexter Tadiwanashe; Musarurwa, Cuthbert; Mapira, Herbert T.; Kaseke, Farayi; Nyengerai, Tawanda; Kaseke, Timothy; Gori, Elizabeth(Dove Medical Press, 2024-08)
PURPOSE : Type 2 diabetes mellitus (T2DM) frequently presents with modified cardiometabolic risk profiles, indicative of an elevated susceptibility to cardiovascular disease (CVD). Cardiometabolic risk factors such as ...
Worsley, Catherine M.; Veale, Rob B.; Mayne, Elizabeth S.(Elsevier, 2024-06)
Cancer cells influence their microenvironment by secreting factors that promote tumour growth and survival while evading immune-mediated destruction. We previously determined the expression of secreted factors in breast ...
Peta, Kimberly; Durandt, Chrisna; Van Heerden, Marlene B.; Joubert, Anna Margaretha; Pepper, Michael Sean; Ambele, Melvin Anyasi(Wiley, 2024-04)
BACKGROUND :
The anti-cancer agent 2-methoxyestradiol (2-ME) has been shown to have anti-proliferative and anti-angiogenic properties. Previously, the effect of 2-ME on early- and late-stage breast cancer (BC) was ...
Ngoepe, Tlou A.; Pretorius, Alri; Steyn, Helena C.; Van Kleef, Mirinda(AOSIS, 2023-03-23)
Cowdria polymorphic gene 1 (cpg1, Erum2510, ERUM_RS01380) has been shown to induce 30%
and 100% protection in sheep immunised by deoxyribonucleic acid (DNA) prime combined with
DNA boost and DNA prime combined with protein ...
Richardson, Simone I.; Mzindle, Nonkululeko; Motlou, Thopisang; Manamela, Nelia; Van der Mescht, Mieke Adri; Lambson, Bronwen E.; Everatt, Josie; Amoako, Daniel Gyamfi; Balla, Sashkia; Von Gottberg, Anne; Wolter, Nicole; De Beer, Zelda; De Villiers, Talita Roma; Bodenstein, Annie; Van den Berg, Gretha; Abdullah, Fareed; Rossouw, Theresa M.; Boswell, M.T.; Ueckermann, Veronica; Bhiman, Jinal N.; Moore, Penny L.(American Society for Microbiology, 2024-07)
SARS-CoV-2 variants of concern (VOCs) differentially trigger neutralizing and antibody-dependent cellular cytotoxic (ADCC) antibodies with variable cross-reactivity. Omicron BA.4/5 was approved for inclusion in bivalent ...
Kroeze, Stefanie; Kootstra, Neeltje; Van Nuenen, Ad C.; Rossouw, Theresa M.; Kityo, Cissy M.; Siwale, Margaret; Akanmu, Sulaimon; Mandaliya, Kishor; De Jager, Marleen; Ondoa, Pascale; Wit, Ferdinand W.; Reiss, Peter; Rinke de Wit, Tobias F.; Hamers, Raph L.(Lippincott, Williams & Wilkins, 2024-05)
OBJECTIVE: This study investigated the association of plasma microRNAs before and during
antiretroviral therapy (ART) with poor CD4þ T-cell recovery during the first year of ART.
DESIGN: MicroRNAs were retrospectively ...
BACKGROUND :
Outcomes of cystic fibrosis (CF) differ between low-middle income and high-income countries, but comparative data are lacking. We compared South African (SA) and Canadian CF outcomes to explore what disparities ...
Van der Mescht, Mieke Adri; De Beer, Zelda; Steel, Helen C.; Anderson, Ronald; Masenge, Andries; Moore, Penny L.; Bastard, Paul; Casanova, Jean-Laurent; Abdullah, Fareed; Ueckermann, Veronica; Rossouw, Theresa M.(Elsevier, 2024-09)
The African continent reported the least number of COVID-19 cases and deaths of all the continents, although the exact reasons for this are still unclear. In addition, little is known about the immunological profiles ...
In the present experiments, we tested the conclusion from previous electrophysiological
experiments that gavage of sweet food and systemically applied insulin both
stimulate oxytocin secretion. To do so, we measured ...
Chesney, Jason A.; Ribas, Antoni; Long, Georgina V.; Kirkwood, John M.; Dummer, Reinhard; Puzanov, Igor; Hoeller, Christoph; Gajewski, Thomas F.; Gutzmer, Ralf; Rutkowski, Piotr; Demidov, Lev; Arenberger, Petr; Shin, Sang Joon; Ferrucci, Pier Francesco; Haydon, Andrew; Hyngstrom, John; Van Thienen, Johannes V.; Haferkamp, Sebastian; Guilera, Josep Malvehy; Rapoport, Bernardo Leon; VanderWalde, Ari; Diede, Scott J.; Anderson, James R.; Treichel, Sheryl; Chan, Edward L.; Bhatta, Sumita; Gansert, Jennifer; Hodi, Frank Stephen; Gogas, Helen(American Society of Clinical Oncology, 2023-01)
PURPOSE : The combination of talimogene laherparepvec (T-VEC) and pembrolizumab previously demonstrated
an acceptable safety profile and an encouraging complete response rate (CRR) in patients with advanced
melanoma in ...